Loading...
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer
Phenylbutyrate (PB) is a histone deacetylase antagonist that also exhibits antitumor activity. In this study, we used 7 breast cancer cell lines to identify biomarker candidates that predict PB sensitivity in breast cancer. Comprehensive gene expression profiles were compared using microarrays, and...
Saved in:
Published in: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Impact Journals LLC
2015
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4811494/ https://ncbi.nlm.nih.gov/pubmed/26646320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|